Physician profile
Ryan D Christensen
NPI 1790999654
$1,146.46
in general payments reported to CMS, 2019-2025
9 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.35 · 2020: $113 · 2021: $31.80 · 2022: $86.19 · 2023: $34.15 · 2024: $450 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $484.99 | 2019-2025 | Constellation |
| Abbott Laboratories | $164.84 | 2024 | Amplatzer Amulet |
| Regeneron Healthcare Solutions, INC. | $160.42 | 2019-2025 | Eylea Hd, Eylea |
| Alimera Sciences, INC. | $124.53 | 2019-2024 | Iluvien, Yutiq |
| Abbvie INC. | $88.13 | 2024-2025 | |
| Genentech USA, INC. | $49.85 | 2021-2022 | |
| Allergan, INC. | $36.26 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $19.19 | 2020 | |
| Apellis Pharmaceuticals, INC. | $18.25 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.